Cargando…
Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235579/ https://www.ncbi.nlm.nih.gov/pubmed/34172087 http://dx.doi.org/10.1186/s40478-021-01210-w |
_version_ | 1783714352221650944 |
---|---|
author | Lian, Xiaolei Kats, Dina Rasmussen, Samuel Martin, Leah R. Karki, Anju Keller, Charles Berlow, Noah E. |
author_facet | Lian, Xiaolei Kats, Dina Rasmussen, Samuel Martin, Leah R. Karki, Anju Keller, Charles Berlow, Noah E. |
author_sort | Lian, Xiaolei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8235579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82355792021-06-28 Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma Lian, Xiaolei Kats, Dina Rasmussen, Samuel Martin, Leah R. Karki, Anju Keller, Charles Berlow, Noah E. Acta Neuropathol Commun Correction BioMed Central 2021-06-25 /pmc/articles/PMC8235579/ /pubmed/34172087 http://dx.doi.org/10.1186/s40478-021-01210-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Lian, Xiaolei Kats, Dina Rasmussen, Samuel Martin, Leah R. Karki, Anju Keller, Charles Berlow, Noah E. Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title | Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title_full | Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title_fullStr | Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title_full_unstemmed | Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title_short | Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
title_sort | correction to: design considerations of an il13rα2 antibody–drug conjugate for difuse intrinsic pontine glioma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235579/ https://www.ncbi.nlm.nih.gov/pubmed/34172087 http://dx.doi.org/10.1186/s40478-021-01210-w |
work_keys_str_mv | AT lianxiaolei correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT katsdina correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT rasmussensamuel correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT martinleahr correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT karkianju correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT kellercharles correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma AT berlownoahe correctiontodesignconsiderationsofanil13ra2antibodydrugconjugatefordifuseintrinsicpontineglioma |